Men's HealthAsad K. Niazi, MD, MPH
Board Certification
Internal Medicine (ABIM)
Alma Mater
Texas Tech University – Foster School of Medicine
Sexual Health
Prescription treatment
First order
Offer ends August 31 at 11:59 PM MST. 10% discount applies to first order only.
Start
Answer a few questions about your health and goals.
⏱ 5-10 minutes
Review
They decide whether treatment is appropriate. No video visit required in 41 states.
⏱ <4 business hours
Delivered
One of our trusted pharmacy partners discreetly ships your medication to your doorstep.
⏱ <1 week*
*Timelines shown reflect our average turnaround times and are not guaranteed.
4.8 average. Patients love us. And we work hard to earn it.
Men's HealthBoard Certification
Internal Medicine (ABIM)
Alma Mater
Texas Tech University – Foster School of Medicine
LongevityBoard Certification
Family Medicine (ABFM)
Alma Mater
Xavier University School of Medicine
LongevityBoard Certification
Family Medicine (ABFM)
Alma Mater
Xavier University School of Medicine
Men's HealthBoard Certification
Physical Medicine and Rehabilitation (ABPMR)
Alma Mater
Lake Erie College of Osteopathic Medicine
Oversight
Physician reviewed
Dose
PT-141 (bremelanotide) is a peptide that acts on the brain's melanocortin pathway to support sexual desire and arousal — a different mechanism than blood-flow medications like tadalafil or sildenafil. Delivered as a needle-free nasal spray.
Frequency
As prescribed
Included
Medication, supplies, expedited shipping
Tadalafil Daily is an erectile dysfunction treatment that allows you to get an erection when you need one — without timing a tablet beforehand. Effective in over 85% of men.
Starting at $90
Ignite combines Tadalafil and Sildenafil in one powerful compounded rapid-dissolving tablet — the fast action of Sildenafil with the long-lasting effects of Tadalafil.
Starting at $125
*PT-141 (bremelanotide) nasal spray is a compounded peptide and is not FDA-approved in this form. Compounded medications have not undergone FDA premarket review for safety, effectiveness, or quality. Not recommended for patients with uncontrolled hypertension or known cardiovascular disease. Do not exceed one dose per 24 hours or 8 doses per month.
1 Kingsberg SA, et al. (2019). Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstet Gynecol. 134(5):899–908.





